Fayda, Merdan2024-05-192024-05-1920230167-81401879-0887https://doi.org10.1016/j.radonc.2023.109722https://hdl.handle.net/20.500.12713/5740[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessBreast-CancerNeoadjuvant ChemotherapyInternal MammaryIrradiationBiopsyHaving ypN0 may not be enough to abandon the Postmastectomy Radiotherapy (PMRT) in Her-2 positive patientsLetter18537244359WOS:0010223338000012-s2.0-85161277069N/A10.1016/j.radonc.2023.109722Q1